2017
DOI: 10.1016/j.neurobiolaging.2017.06.003
|View full text |Cite|
|
Sign up to set email alerts
|

Central insulin dysregulation and energy dyshomeostasis in two mouse models of Alzheimer's disease

Abstract: Alzheimer’s disease (AD) is the most prevalent neurodegenerative disorder worldwide. While the causes of AD are not known, several risk factors have been identified. Among these, type 2 diabetes (T2D), a chronic metabolic disease, is one of the most prevalent risk factors for AD. Insulin resistance, which is associated with T2D, is defined as diminished or absent insulin signaling, and is reflected by peripheral blood hyperglycemia and impaired glucose clearance. In this study, we used complimentary approaches… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
69
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 73 publications
(72 citation statements)
references
References 99 publications
(167 reference statements)
3
69
0
Order By: Relevance
“…whether their brains becomes insensitive to insulin). On the one hand, Ho et al proposed that Tg2576 and 3xTg-AD models develop central insulin signaling dysregulation prior to peripheral insulin resistance [81]. In contrast, Stanley et al showed by direct central insulin delivery, that the brain from old APP/PS1 mice is still responsive to insulin even in the presence of aberrant amyloidosis [42].…”
Section: B) Central Insulin Resistance In T2dm and Ad Animal Modelsmentioning
confidence: 99%
“…whether their brains becomes insensitive to insulin). On the one hand, Ho et al proposed that Tg2576 and 3xTg-AD models develop central insulin signaling dysregulation prior to peripheral insulin resistance [81]. In contrast, Stanley et al showed by direct central insulin delivery, that the brain from old APP/PS1 mice is still responsive to insulin even in the presence of aberrant amyloidosis [42].…”
Section: B) Central Insulin Resistance In T2dm and Ad Animal Modelsmentioning
confidence: 99%
“…Mouse proteins were prepared as previously described (Velazquez, Shaw, Caccamo & Oddo, 2016; Velazquez et al., 2017). One hemisphere of the brain was postfixed in 4% paraformaldehyde for 48 hr while the other hemisphere had the hippocampus and cortex isolated, flash‐frozen in dry ice, and stored at −80°C.…”
Section: Methodsmentioning
confidence: 99%
“…Dysregulations in insulin signaling have been reported in postmortem hippocampal and cortical samples from subjects with AD [86]. Another study observed an age-dependent progression in insulin signaling dysregulation that precedes peripheral insulin resistance in two preclinical AD models [87]. Hippocampal dysfunction and structural compromise are one of the early signs during AD onset [87-91].…”
Section: Endocrinal Dysregulations In the Ad Pathophysiologymentioning
confidence: 99%
“…Another study observed an age-dependent progression in insulin signaling dysregulation that precedes peripheral insulin resistance in two preclinical AD models [87]. Hippocampal dysfunction and structural compromise are one of the early signs during AD onset [87-91]. Insulin plays a very important role in AD progression by various complex mechanisms [92].…”
Section: Endocrinal Dysregulations In the Ad Pathophysiologymentioning
confidence: 99%